487 related articles for article (PubMed ID: 11125420)
1. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
[TBL] [Abstract][Full Text] [Related]
2. Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
Perabo FG; Demant AW; Wirger A; Schmidt DH; Sitia M; Wardelmann E; Müller SC; Kohn EC
Anticancer Res; 2005; 25(2A):725-9. PubMed ID: 15868902
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
4. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
[TBL] [Abstract][Full Text] [Related]
5. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
Kemberling JK; Hampton JA; Keck RW; Gomez MA; Selman SH
J Urol; 2003 Sep; 170(3):773-6. PubMed ID: 12913695
[TBL] [Abstract][Full Text] [Related]
9. Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
Fujiyama C; Jones A; Fuggle S; Bicknell R; Cranston D; Harris AL
Br J Cancer; 2001 Feb; 84(4):558-64. PubMed ID: 11207054
[TBL] [Abstract][Full Text] [Related]
10. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
Zou C; Liebert M; Zou C; Grossman HB; Lotan R
J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
12. Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression.
Chen SC; Henry DO; Hicks DG; Reczek PR; Wong MK
J Urol; 2009 Jan; 181(1):336-42. PubMed ID: 19010488
[TBL] [Abstract][Full Text] [Related]
13. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
15. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
[TBL] [Abstract][Full Text] [Related]
18. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus.
Kawai K; Kawamata H; Kemeyama S; Rademaker A; Oyasu R
Cancer Res; 1994 May; 54(10):2630-2. PubMed ID: 8168089
[TBL] [Abstract][Full Text] [Related]
19. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
[TBL] [Abstract][Full Text] [Related]
20. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
